Zealand Pharma A/S (ZLDPF)
51.80
+3.56
(+7.39%)
USD |
OTCM |
Aug 25, 16:00
Zealand Pharma Shareholders Equity (Quarterly) : 2.753B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.753B |
| March 31, 2026 | 2.231B |
| December 31, 2025 | 2.332B |
| September 30, 2025 | 2.387B |
| June 30, 2025 | 2.456B |
| March 31, 2025 | 1.203B |
| December 31, 2024 | 1.197B |
| September 30, 2024 | 1.330B |
| June 30, 2024 | 1.350B |
| March 31, 2024 | 410.91M |
| December 31, 2023 | 236.03M |
| September 30, 2023 | 257.95M |
| June 30, 2023 | 253.11M |
| March 31, 2023 | 98.19M |
| December 31, 2022 | 117.10M |
| September 30, 2022 | 48.28M |
| June 30, 2022 | 70.99M |
| March 31, 2022 | 106.16M |
| December 31, 2021 | 141.86M |
| September 30, 2021 | 184.81M |
| June 30, 2021 | 221.15M |
| March 31, 2021 | 262.76M |
| December 31, 2020 | 202.07M |
| September 30, 2020 | 250.48M |
| June 30, 2020 | 271.24M |
| Date | Value |
|---|---|
| March 31, 2020 | 178.71M |
| December 31, 2019 | 186.67M |
| September 30, 2019 | 205.77M |
| June 30, 2019 | 147.51M |
| March 31, 2019 | 163.08M |
| December 31, 2018 | 171.00M |
| September 30, 2018 | 193.26M |
| June 30, 2018 | 49.56M |
| March 31, 2018 | 69.68M |
| December 31, 2017 | 83.01M |
| September 30, 2017 | 101.51M |
| June 30, 2017 | 27.85M |
| March 31, 2017 | 36.34M |
| December 31, 2016 | 39.46M |
| September 30, 2016 | 32.85M |
| June 30, 2016 | 16.06M |
| March 31, 2016 | 42.55M |
| December 31, 2015 | 36.72M |
| September 30, 2015 | 23.85M |
| June 30, 2015 | 24.35M |
| March 31, 2015 | 30.07M |
| December 31, 2014 | 41.09M |
| September 30, 2014 | 53.66M |
| June 30, 2014 | 54.98M |
| March 31, 2014 | 63.69M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Genmab A/S | 5.957B |
| Ascendis Pharma A/S | 1.642B |
| Bavarian Nordic A/S | 2.022B |
| Evaxion AS | 9.531M |
| Novo Nordisk A/S | 33.84B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.023B |
| Total Liabilities (Quarterly) | 269.50M |
| Debt to Equity Ratio | 0.0228 |
| Current Ratio | 13.98 |
| Net Debt Paydown Yield | -0.04% |